Search research articles
Contact Us
Filters
Showing results (101-110 of 122) with videos related to
Page
of 13
Sort By:
MMWR. Morbidity and Mortality Weekly Report
|
April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Nature Communications
|
July 27, 2022
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
Li Wang, Markus H Kainulainen, Nannan Jiang, et al.
MMWR. Morbidity and Mortality Weekly Report
|
October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022
Diya Surie, Levi Bonnell, Katherine Adams, et al.
MMWR. Morbidity and Mortality Weekly Report
|
October 5, 2023
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023
Diya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
Vaccine
|
November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States
Caitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.
The Journal of Infectious Diseases
|
April 6, 2022
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients
Jennie H Kwon, Mark W Tenforde, Manjusha Gaglani, et al.
Annals of Internal Medicine
|
December 20, 2021
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial
, Jens D Lundgren, Birgit Grund, et al.
JAMA
|
November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W Tenforde, Wesley H Self, Katherine Adams, et al.
Open Forum Infectious Diseases
|
January 25, 2023
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
Nathaniel M Lewis, Nancy Murray, Katherine Adams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 17, 2022
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States
Mark W Tenforde, Wesley H Self, Yuwei Zhu, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 122) with videos related to
Sort By:
Page
of 13
MMWR. Morbidity and Mortality Weekly Report
|
April 27, 2023
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
Nature Communications
|
July 27, 2022
Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines
Li Wang, Markus H Kainulainen, Nannan Jiang, et al.
MMWR. Morbidity and Mortality Weekly Report
|
October 20, 2022
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022
Diya Surie, Levi Bonnell, Katherine Adams, et al.
MMWR. Morbidity and Mortality Weekly Report
|
October 5, 2023
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023
Diya Surie, Katharine A Yuengling, Jennifer DeCuir, et al.
Vaccine
|
November 14, 2022
Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States
Caitlin Turbyfill, Katherine Adams, Mark W Tenforde, et al.
The Journal of Infectious Diseases
|
April 6, 2022
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients
Jennie H Kwon, Mark W Tenforde, Manjusha Gaglani, et al.
Annals of Internal Medicine
|
December 20, 2021
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial
, Jens D Lundgren, Birgit Grund, et al.
JAMA
|
November 4, 2021
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Mark W Tenforde, Wesley H Self, Katherine Adams, et al.
Open Forum Infectious Diseases
|
January 25, 2023
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022
Nathaniel M Lewis, Nancy Murray, Katherine Adams, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 17, 2022
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States
Mark W Tenforde, Wesley H Self, Yuwei Zhu, et al.
Page
of 13